A low-saturated-fat, low-cholesterol diet decreases plasma CETP activity and pre β-HDL formation but does not affect cellular cholesterol efflux to plasma from type 1 diabetic patients

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 65, Issue 8, 2005, Pages 729-738

  De Vries, R ^a   Beusekamp, B J ^a   Kerstens, M N ^a   Groen, A K ^b   Van Tol, A ^a,c   Dullaart, R P F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cellular cholesterol efflux; Diet intervention; High density lipoproteins; Lipid transfer proteins; Type 1 diabetes melllitus

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID TRANSFER PROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANIMAL CELL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL ESTERIFICATION; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SUBSTRATE; FIBROBLAST; HEPATOMA CELL; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOELECTROPHORESIS; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CELL CULTURE; LOW FAT DIET; MALE; NONHUMAN; NUTRIENT LOADING; NUTRITIONAL VALUE; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 28744452208     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510500375289     Document Type: Article

References (38)

1. Truswell AS. Review of dietary intervention studies: effect on coronary events and on total mortality. Aust NZ J Med 1994;24:98-106.
2. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987;59:750-5.
3. American Diabetes Association. Nutrition principles and recommendations in diabetes. Diab Care 2004;27:S36-46.
4. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992;12:911-19.
5. Blanco-Molina A, Castro G, Martin-Escalante D, Bravo D, Lopez-Miranda J, Castro P, et al. Effects of different dietary cholesterol concentrations on lipoprotein plasma concentrations and on cholesterol efflux from Fu5AH cells. Am J Clin Nutr 1998;68:1028-33.
6. Jansen S, Lopez-Miranda J, Castro P, Lopez-Segura F, Marton C, Ordovas JM, et al. Low-fat and high monounsaturated fatty acid diets decrease plasma cholesterol ester transfer protein concentrations in young, healthy, normolipemic men. Am J Clin Nutr 2000;72:36-41.
7. Martin LJ, Connelly PW, Nancoo D, Wood N, Zhang ZJ, Maguire G, et al. Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apo-E genotype. J Lipid Res 1993;34:437-46.
8. Blaauwwiekel EE, Beusekamp BJ, Sluiter WJ, Hoogenberg K, Dullaart RPF. Apolipoprotein E genotype is a determinant of low-density lipoprotein cholesterol and of its response to a low-cholesterol diet in Type 1 diabetic patients with elevated urinary albumin excretion. Diabet Med 1998;15:1031-5.
9. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995;36:211-28.
10. Barter PJ, Rye KA. High density lipoproteins and reverse cholesterol transport. Curr Opin Lipidol 1993;4:210-17.
11. Jauhiainen M, Metso J, Pahlman R, Blomqvist S, Van Tol A, Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 1993;268:4032-6.
12. Rye KA, Clay MA, Barter PJ. Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 1999;145:227-38.
13. Miida T, Yamaguchi H, Tsuda T, Okada M. High pre-beta1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low-cholesterol diet. Atherosclerosis 1998;138:129-34.
14. Sola R, Motta C, Maille M, Bargallo MT, Boisnier C, Richard JL, et al. Dietary monounsaturated fatty acids enhance cholesterol efflux from human fibroblasts. Relation to fluidity, phospholipid fatty acid composition, overall composition, and size of HDL3. Arterioscler Thromb 1993;13:958-66.
15. Gillotte KL, Lund-Katz S, De La Llera-Moya M, Parks JS, Rudel LL, Rothblat GH, et al. Dietary modification of high density lipoprotein phospholipid and influence on cellular cholesterol efflux. J Lipid Res 1998;39:2065-75.
16. Van Staveren WA, Hulshof KFAM. De voedingsanamnese in het voedingsonderzoek, mogelijkheden en beperkingen. Voeding 1980;41:228-32.
17. Dullaart RPF, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994;24:188-94.
18. Speijer H, Groener JE, Van Ramshorst E, Van Tol A. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis 1991;90:159-68.
19. Groener JE, Pelton RW, Kostner GM. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem 1986;32:283-6.
20. Van Haperen R, Van Tol A, Vermeulen P, Jauhiainen M, Van Gent T, Van den Berg P, et al. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol 2000;20:1082-8.
21. Brussaard JH, Dallinga-Thie GM, Groot PHE, Katan MB. Effects of amount and type of dietary fat on serum lipids, lipoproteins and apolipoproteins in man. A controlled 8-week trial. Atherosclerosis 1980;36:515-27.
22. Hovingh GK, Wijland MJ, Brownlie A, Bisoendial RJ, Hayden MR, Kastelein JJ, et al. The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia. J Lipid Res 2003;44:1251-5.
23. Denis M, Bissonnette R, Haidar B, Krimbou L, Bouvier M, Genest J. Expression, regulation, and activity of ABCA1 in human cell lines. Mol Genet Metab 2003;78:265-74.
24. Gillotte-Tayler K, Nickel M, Johnson WJ, Francone OL, Holvoet P, Rothblat GH, et al. Effects of enrichment of fibroblasts with unesterified cholesterol on the efflux of cellular lipids to apolipoprotein A-I. J Biol Chem 2002;277:11811-20.
25. Dullaart RPF, Van Tol A. Twenty-four hour-insulin infusion impairs the ability of plasma from healthy subjects and type 2 diabetic patients to promote cellular cholesterol efflux. Atherosclerosis 2001;157:49-56.
26. Rothblat GH, De La Llera-Moya M, Atger V, Kellner-Weibel G, Williams DL, Phillips MC. Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 1999;40:781-96.
27. De La Llera-Moya M, Atger V, Paul JL, Fournier N, Moatti N, Giral P, et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb 1994;14:1056-65.
28. Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA 2004;101:9774-9.
29. Fournier N, Paul JL, Atger V, Cogny A, Soni T, De La Llera-Moya M, et al. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 1997;17:2685-91.
30. Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-b-migrating high-density lipoprotein. Biochemistry 1988;27:25-9.
31. Oram J, Wolfbauer G, Vecchio G, Albers JJ. Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells. J Biol Chem 2003;26:52379-85.
32. Montoya MT, Porres A, Serrano S, Fruchart JC, Mata P, Gómez Gerique JA, et al. Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacity. Am J Clin Nutr 2002;75:484-91.
33. Meijer GW, Groener JE, Beynen AC, Van Tol A. Lowering of serum cholesteryl ester transfer protein - but not lecithin:cholesterol acyltransferase - activity levels by hypocholesterolemic drugs in the rabbit. Cardiovasc Drugs Ther 1998;12:13-18.
34. Lichtenstein AH, Ausman LM, Jalbert SM, Vilella-Bach M, Jauhiainen M, McGladdery S, et al. Efficacy of a Therapeutic Lifestyle Change/Step 2 diet in moderately hypercholesterolemic middle-aged and elderly female and male subjects. J Lipid Res 2002;43:264-73.
35. Dullaart RPF, De Vries R, Scheck LM, Borggreve SE, Van Gent T, Dallinga-Thie GM, et al. Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations. Scand J Clin Lab Invest 2004;64:205-16.
36. McPherson R, Lau P, Russie P, Tall AR. Plasma kinetics of cholesteryl ester transfer protein in the rabbit. Effects of dietary cholesterol. Arterioscler Thromb Vasc Biol 1997;17:203-10.
37. Rye KA, Jensen G, Barter PJ, Ehnholm C. Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein. J Lipid Res 1998;39:613-22.
38. Boekholdt SM, Kuivenhoven JA, Hovingh GK, Jukema JW, Kastelein JJP, Van Tol A. CETP gene variation: relation to lipid parameters and cardiovascular risk. Curr Opin Lipidol 2004;15:393-8.